In 2024, HIV/AIDS deaths in Kenya were highest among the 35-44 age group, with 733 fatalities recorded. This was followed by ...

A federal judge extended a temporary legal block that prevents Idaho from verifying the immigration status of people ...

Experts are celebrating a breakthrough in HIV prevention. Doctors say it could mean we're one step closer to eradicating the decades-old epidemic. As CBS News New York's John Dias explains, there's ...

After the virologic failure of cabotegravir/rilpivirine and despite dual-class resistance mutations, Canadian doctors have had surprising success with a single pill ...

The FDA has approved a breakthrough preventative treatment for HIV that could change the course of the AIDS epidemic. But deep cuts to health initiatives could hinder the rollout. Lenacapavir not ...

So despite the success of HIV drugs and PrEP, precarious health-care systems and high drug costs mean we can’t rely on them to bring an end to the ongoing global HIV pandemic.

Since 1995, National HIV Testing Day has raised awareness and confronted stereotypes about HIV. Learn about HIV testing options and prevention methods.

The Trump administration has lifted a freeze on federal funds for HIV prevention and surveillance programs, officials said, following an outcry from HIV prevention organizations, health experts ...

MIT's new dual-adjuvant vaccine offers strong HIV protection with a single dose, potentially aiding in the fight against challenging viruses.

Gilead’s daily antiviral pills can prevent HIV transmission and slow AIDS. While an HIV vaccine remains the Holy Grail, Gilead’s new long-lasting injection, lenacapavir, is the next best thing.

Utah biochemist Wesley Sundquist has achieved yet another milestone with the Food and Drug Administration approval of an antiviral drug for HIV prevention based on his findings.

While a vaccine to prevent HIV still is needed, some experts say this new shot could be the next best thing.